We are live on
!
Find out more
Axa Portfolio holdings
AUM
$256M
1-Year Est. Return
25.01%
This Fund
S&P 500
This Quarter
Est. Return
+16.76%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$25.6B
AUM Growth
+$2.65B
(+12%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-4.57%
Top 10 Holdings %
Top 10 Hldgs %
14.38%
Holding
1,445
New
151
Increased
481
Reduced
509
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$56.6M |
| 2 |
Fidelity National Information Services
FIS
|
+$53M |
| 3 |
Advanced Micro Devices
AMD
|
+$48.1M |
| 4 |
RTX Corp
RTX
|
+$43.3M |
| 5 |
Analog Devices
ADI
|
+$38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$72.1M |
| 2 |
PepsiCo
PEP
|
+$70.8M |
| 3 |
American Express
AXP
|
+$70.7M |
| 4 |
Automatic Data Processing
ADP
|
+$49.7M |
| 5 |
Synchrony
SYF
|
+$47.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.3% |
| 2 | Healthcare | 15.12% |
| 3 | Consumer Discretionary | 10% |
| 4 | Financials | 9.68% |
| 5 | Industrials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Prothena Corp
PRTA
$448M
| $333K | ﹤0.01% |
27,460
| – | – |
|
1152
AMC Entertainment Holdings
AMC
$2.45B
| $331K | ﹤0.01% |
2,230
+430
| +24% | +$61.2K |
|
1153
Annaly Capital Management
NLY
$17.3B
| $327K | ﹤0.01% |
+8,188
| New | +$334K |
|
1154
Regenxbio
RGNX
$616M
| $327K | ﹤0.01% |
5,700
-28,400
| -83% | -$1.41M |
|
|
CTT
1155
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $326K | ﹤0.01% |
+33,164
| New | +$303K |
|
1156
Huntington Ingalls Industries
HII
$11B
| $323K | ﹤0.01% |
1,559
-3,127
| -67% | -$641K |
|
|
PFNX
1157
DELISTED
Pfenex Inc.
PFNX
| $323K | ﹤0.01% |
52,323
+42,323
| +423% | +$185K |
|
1158
United Microelectronic
UMC
$42.9B
| $320K | ﹤0.01% |
170,305
| – | – |
|
|
ACOR
1159
DELISTED
Acorda Therapeutics
ACOR
| $320K | ﹤0.01% |
201
-24
| -11% | -$43.2K |
|
|
PRAH
1160
DELISTED
PRA Health Sciences, Inc.
PRAH
| $320K | ﹤0.01% |
+2,900
| New | +$303K |
|
|
CARB
1161
DELISTED
Carbonite Inc
CARB
| $320K | ﹤0.01% |
12,918
| – | – |
|
1162
Weyco Group
WEYS
$377M
| $319K | ﹤0.01% |
10,288
-6,799
| -40% | -$200K |
|
1163
Ambev
ABEV
$47.9B
| $317K | ﹤0.01% |
73,716
+4,600
| +7% | +$21.1K |
|
1164
Lexicon Pharmaceuticals
LXRX
$1.03B
| $315K | ﹤0.01% |
+56,600
| New | +$344K |
|
1165
Tenet Healthcare
THC
$22.2B
| $314K | ﹤0.01% |
10,900
-15,900
| -59% | -$393K |
|
|
ETFC
1166
DELISTED
E*Trade Financial Corporation
ETFC
| $312K | ﹤0.01% |
6,700
-8,553
| -56% | -$407K |
|
|
ELME
1167
Elme Communities
ELME
$145M
| $311K | ﹤0.01% |
10,945
| – | – |
|
1168
Upland Software
UPLD
$13.3M
| $309K | ﹤0.01% |
+730
| New | +$248K |
|
1169
KeyCorp
KEY
$23.8B
| $306K | ﹤0.01% |
19,443
-34,696
| -64% | -$579K |
|
1170
World Kinect Corp
WKC
$2.07B
| $303K | ﹤0.01% |
10,500
+600
| +6% | +$15.8K |
|
1171
Freeport-McMoran
FCX
$86.2B
| $302K | ﹤0.01% |
+23,459
| New | +$284K |
|
1172
Kamada
KMDA
$404M
| $302K | ﹤0.01% |
+52,746
| New | +$297K |
|
1173
iShares MSCI Poland ETF
EPOL
$680M
| $300K | ﹤0.01% |
13,100
| – | – |
|
1174
iShares MSCI Netherlands ETF
EWN
$552M
| $299K | ﹤0.01% |
9,993
| – | – |
|
|
MOBL
1175
DELISTED
MobileIron, Inc.
MOBL
| $299K | ﹤0.01% |
+54,700
| New | +$270K |
|
Similar funds
PHAM
HFRG
EBWM
GCCM
CIA
KAM
ACM
CCA
Axa's Q1 2019 Portfolio in Review
As of Q1 2019, Axa held 1,445 positions worth $25.6B, up 12% from $22.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa withdrew a net $1.17B in Q1 2019, closing 137 positions and reducing 509 holdings. Its most notable exit was Newfield Exploration, an estimated $15.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Axa opened a new position in BlackBerry worth $40.1M.
- Axa's largest Q1 2019 buy was BlackBerry: 3,971,844 shares worth $40.1M.
- Axa added most to Gilead Sciences in Q1 2019, an estimated $56.6M increase.
- Axa's biggest Q1 2019 reduction was Humana, cutting an estimated $72.1M.
- Axa fully exited Newfield Exploration in Q1 2019, selling an estimated $15.3M.
- Axa's ten largest holdings make up 14% of its $25.6B portfolio in Q1 2019.
- Axa opened 151 new positions and closed 137 in Q1 2019.
- Axa's portfolio value rose 12% quarter-over-quarter to $25.6B.
Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.